About Allergan Medical
Allergan Medical, a division of Allergan, Inc., offers the most comprehensive, science-based, aesthetic product offerings under its Total Facial Rejuvenation portfolio, including BOTOX(R) Cosmetic; hyaluronic acid and collagen-based dermal fillers; and physician-dispensed skin care products. Allergan Medical also offers the industry's widest range of breast implant options for reconstructive and aesthetic breast surgery, and leading minimally invasive devices for obesity intervention treatment.
This press release contains "forward-looking statements", including statements by Ms. Comaneci, Mr. Spitz and Dr. Wechsler and statements regarding research and development outcomes, efficacy, adverse events, market and product potential and other statements regarding BOTOX(R) Cosmetic.
These statements are based on current expectations of future events. If
underlying assumptions prove inaccurate or unknown risks or uncertainties
materialize, actual results could vary materially from Allergan's
expectations and projections. Risks and uncertainties include, among other
things, general industry and market conditions; technological advances and
patents attained by competitors; challenges inherent in the research and
development and regulatory processes; challenges related to product
marketing, such as the unpredictability of market acceptance for new
products and/or the acceptance of new indications for such products;
inconsistency of treatment results among patients and the potential for
product failures; unknown risks associated with the investigational devices
that are the subject of clinical trials; potential difficulties in
|SOURCE Allergan, Inc.|
Copyright©2008 PR Newswire.
All rights reserved